Improvement of masseter spasticity by botulinum toxin facilitates PEG placement in amyotrophic lateral sclerosis [3]

Gastroenterology

Volumn 123, Issue 5, 2002, Pages 1749-1750

  Restivo, Domenico A ^a   Lanza, Sara ^a   Marchese Ragona, Rosario ^a   Palmeri, Agostino ^a  

^a UNIVERSITY OF CATANIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; BOTULINUM TOXIN A;

ADULT; AMYOTROPHIC LATERAL SCLEROSIS; ASPIRATION PNEUMONIA; CLINICAL ARTICLE; DYSPHAGIA; ELECTROMYOGRAPHY; HUMAN; LETTER; MASSETER MUSCLE; PERCUTANEOUS ENDOSCOPIC GASTROSTOMY; PRIORITY JOURNAL; SPASTICITY; STOMACH INTUBATION;

EID: 0036829754     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/gast.2002.36877     Document Type: Article

References (5)

1. Mazzini L, Corrà T, Zaccala M, Mora G, Del Piano M, Galante M. Percutaneous endoscopic gastrostomy and enteral nutrition in amyotrophic lateral sclerosis. J Neurol 1995;242:695-698.
2. Park DM. Spasticity in adults. In: Moore P, ed. Handbook of Botulinum Toxin Treatment. Blackwell Science, 1999:209-221.
3. Brin MF, Blitzer A, Herman S, Stewart C. Orofaciomandibular and lingual dystonia (Meige syndrome). In: Moore P, ed. Handbook of Botulinum Toxin Treatment. Blackwell Science, 1999:151-163.
4. Restivo DA, Marchese-Ragona R, Palmeri A, Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease. N Engl J Med 2002 (in press).
5. World Federation of Neurology Subcommittee on Motor Neuron Disease. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. J Neurol Sci 1994;124(Suppl):96-107.